Hellenic Cooperative Oncology Group
hecog.grTotal trials
53
Active
3
Phase 3
0
Total enrollment
21,544
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Breast Cancer9
- Non Small Cell Lung Cancer5
- Ovarian Cancer3
- Metastatic Breast Cancer3
- Colorectal Cancer2
- Prostate Cancer2
- NSCLC (Non-small Cell Lung Cancer)1
- Autoimmune Diseases1
Frequently asked questions about Hellenic Cooperative Oncology Group
- How many clinical trials does Hellenic Cooperative Oncology Group have on ClinicalTrials.gov?
- Hellenic Cooperative Oncology Group is listed as the lead sponsor on 53 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hellenic Cooperative Oncology Group's trials are in Phase 3?
- 0 of Hellenic Cooperative Oncology Group's trials are in Phase 3.
- What therapeutic areas does Hellenic Cooperative Oncology Group focus on?
- Hellenic Cooperative Oncology Group's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Non Small Cell Lung Cancer, Ovarian Cancer, Metastatic Breast Cancer, Colorectal Cancer.